Engineered T lymphocytes eliminate lung metastases in models of pancreatic cancer

This publication has 36 references indexed in Scilit:

• Redirected Antitumor Activity of Primary Human Lymphocytes Transduced With a Fully Human Anti-mesothelin Chimeric Receptor
  Molecular Therapy, 2012
• Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent
  Cancer, 2011
• Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
  New England Journal of Medicine, 2011
• Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
  Clinical Cancer Research, 2011
• In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells
  Cancer Immunology, Immunotherapy, 2011
• Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
  Cancer Research, 2010
• Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b
  Journal of Immunotherapy, 2010
• Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
  Proceedings of the National Academy of Sciences, 2009
• Adoptive cell transfer: a clinical path to effective cancer immunotherapy
  Nature Reviews Cancer, 2008
• Mesothelin targeted cancer immunotherapy
  European Journal of Cancer, 2008